The article deals with the issues on further improvement the ongoing reforms in the development of the pharmaceutical industry in Uzbekistan, in the context of the current pandemic worldwide. It describes the funds allocated from the state budget, the quality of medical care, the Actions Strategy measures taken by the state to ensure public health, quality and access to medical care by all segments of the population. The conclusion part highlights the essence of the introduction of scientific achievements and technologies and an in-depth analysis of the growth in the number of primary diseases and ailments among the population of the republic. The reasons for the growth of existing diseases, the measures taken by the state to improve the number and composition of drugs for the prevention have been analysed from retrospective viewpoint. The obstacles and existing problems in the development of the pharmaceutical industry in Uzbekistan have been compared with the experience of developed foreign countries, including Germany. At the same time, well-grounded proposals and recommendations were developed to solve existing problems in this area.